Omniose
St Louis
About Omniose
Omniose is an early stage biotechnological company developing next-generation conjugate vaccines against infectious diseases using our proprietary in vivo conjugating technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Funding stage: Seed
- Last round: Grant (Sep 2023)
- Website: omniose.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/omniose-122803 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.